17. The Role of Treatment Setting in the Pharmacotherapy of Bipolar Disorder

  1. Hagop S. Akiskal2 and
  2. Mauricio Tohen3,4
  1. Jean-Michel Azorin

Published Online: 31 MAY 2006

DOI: 10.1002/0470017953.ch17

Bipolar Psychopharmacotherapy: Caring for the Patient

Bipolar Psychopharmacotherapy: Caring for the Patient

How to Cite

Azorin, J.-M. (2005) The Role of Treatment Setting in the Pharmacotherapy of Bipolar Disorder, in Bipolar Psychopharmacotherapy: Caring for the Patient (eds H. S. Akiskal and M. Tohen), John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/0470017953.ch17

Editor Information

  1. 2

    International Mood Center, Department of Psychiatry at the University of San Diego and Veterans Administration Medical Center, 3350 La Jolla Village Dr. (116-A), San Diego, CA 92161, USA

  2. 3

    McLean Hospital, Harvard Medical School, Belmont, MA, USA

  3. 4

    Lilly Research Laboratories, Eli Lilly & Co, 525 S. Meridian Street, Indianapolis, IN 46225, USA

Author Information

  1. Department of Psychiatry, Ste Marguerite Hospital, 13274 Marseille Cedex 9, France

Publication History

  1. Published Online: 31 MAY 2006
  2. Published Print: 11 NOV 2005

ISBN Information

Print ISBN: 9780470856079

Online ISBN: 9780470017951

SEARCH

Keywords:

  • pretreatment evaluation;
  • monitoring of pharmacotherapy;
  • drug response and treatment setting;
  • enhanced treatment-adherence;
  • humane psychiatric hospitalization;
  • trans-institutionalization phenomenon

Summary

This chapter contains sections titled:

  • Implementation of Drug Treatment according to Phase and Severity of Illness

  • Pretreatment Evaluation and Monitoring of Pharmacotherapy

  • Drug Response and Treatment Setting

  • From Efficacy to Efficiency of Pharmacotherapy in Bipolar Illness

  • References